These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 790444)

  • 1. Physical and radiobiological bases of the use of 125I in the management of thyrotoxicosis.
    Reddy AR
    Radiat Environ Biophys; 1976 Oct; 13(3):205-14. PubMed ID: 790444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological effects of 131I and 125I on the DNA of the rat thyroid. I. Comparative study with emphasis on the postradiation hypothyroidism occurrence.
    Abdel-Nabi H; Ortman JA
    Radiat Res; 1983 Mar; 93(3):525-33. PubMed ID: 6856755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism.
    Alevizaki CC; Alevizaki-Harhalaki MC; Ikkos DG
    Eur J Nucl Med; 1985; 10(9-10):450-4. PubMed ID: 4006987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two mechanisms for hypothyroidism after 131I therapy.
    Malone JF; Cullen MJ
    Lancet; 1976 Jul; 2(7976):73-5. PubMed ID: 59154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis.
    Goolden AW; Stewart JS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):217-22. PubMed ID: 3708873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological effects of 131I and 125I isotopes of iodine in the rat.
    Doniach I; Shale DJ
    J Endocrinol; 1976 Oct; 71(1):109-114. PubMed ID: 978110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment.
    Bednár J; Nĕmec J; Soutorová M; Neradilová M; Pohunková D; Zamrazil V; Vána S; Havelka J; Röhling S
    Endocrinol Exp; 1979 Mar; 13(1):53-63. PubMed ID: 316382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
    Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscopic dose distributions due to iodine isotopes in thyroid.
    Reddy AR; Kaul A
    Radiat Environ Biophys; 1978 Oct; 15(3):229-39. PubMed ID: 746118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hypothyroidism after radioactive iodine therapy for thyrotoxicosis in Hong Kong Chinese.
    Best JD; Chan V; Khoo R; Teng CS; Wang C; Yeung RT
    Clin Radiol; 1981 Jan; 32(1):57-61. PubMed ID: 7214823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of 125I treatment of thyrotoxicosis.
    Bremner WF; Spencer CA; Ratcliffe WA; Greig WR; Ratcliffe JG
    Clin Endocrinol (Oxf); 1976 May; 5(3):225-34. PubMed ID: 954217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease.
    Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Hansen BM; Søe-Jensen P; Hansen JM
    J Intern Med; 1995 Dec; 238(6):491-7. PubMed ID: 9422034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy.
    Connell JM; Hilditch TE; McCruden DC; Robertson J; Alexander WD
    Eur J Nucl Med; 1984; 9(10):464-6. PubMed ID: 6510423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and dosimetry of free 211At, 125I- and 131I- in rats.
    Spetz J; Rudqvist N; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2013 Nov; 28(9):657-64. PubMed ID: 23789969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low doses of radio-iodine for hyperthyroidism. Failure to prevent a high incidence of early hypothyroidism.
    Kalk WJ; Durbach D; Kantor S; Levin J
    S Afr Med J; 1980 Mar; 57(13):479-82. PubMed ID: 7368008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 125I therapy in Graves' disease. Long-term results in 355 patients.
    McDougall IR; Greig WR
    Ann Intern Med; 1976 Dec; 85(6):720-3. PubMed ID: 1036667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis.
    Turner JG; Brownlie BE; Rogers TG
    Lancet; 1976 Mar; 1(7960):614-5. PubMed ID: 55895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the outcome between the calculated dosimetry and the estimated dosimetry of 131I in the treatment of hyperthyroidism.
    Sun JH; Huang HS; Huang MJ; Huang BY; Lin JD; Hsu BR; Chiou SC; Lo SK
    Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):322-8. PubMed ID: 8851980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning of 131I therapy for graves disease based on the radiation dose to thyroid follicular cells.
    Eterovic D; Antunovic Z; Markovic V; Grosev D
    J Nucl Med; 2008 Dec; 49(12):2026-30. PubMed ID: 18997041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.